How much profit has Haemato made this year?
Haemato has made 10.21 M EUR this year.
Haemato Net Income 2024
Haemato Net Income
10.21 M EUR
Haemato Dividend yield
6.4 %
Ticker
HAEK.HM
ISIN
DE000A289VV1
WKN
A289VV
In 2024, Haemato's profit amounted to 10.21 M EUR, a 28.06% increase from the 7.98 M EUR profit recorded in the previous year.
The Haemato Net Income history
| YEAR | NET INCOME (undefined EUR) |
|---|---|
| 2029e | - |
| 2028e | - |
| 2027e | - |
| 2026e | - |
| 2025e | 11.26 |
| 2024e | 10.21 |
| 2023e | 7.98 |
| 2022 | 8.19 |
| 2021 | 6.5 |
| 2020 | -4.8 |
| 2019 | -1.2 |
| 2018 | 6.3 |
| 2017 | 7 |
| 2016 | 11 |
| 2015 | 5.5 |
| 2014 | 7 |
| 2013 | 7.9 |
| 2012 | 6.8 |
| 2011 | 1.5 |
| 2010 | 5.7 |
| 2009 | -5.7 |
| 2008 | 4 |
| 2007 | 2.8 |
| 2006 | 8 |
| 2005 | 1.6 |
| 2004 | 2.9 |
| 2003 | - |
Haemato Aktienanalyse
What does Haemato do?
Haemato AG is a German company specializing in the trade of high-quality pharmaceuticals and medical products. It was founded in 1993 and has become one of the leading companies in this field. The company's goal is to offer quality medications and medical products for the German market. They carefully select products and collaborate with renowned manufacturers and suppliers to ensure success. Haemato AG is divided into different divisions specializing in the trade of various pharmaceuticals and medical products for oncology, pain therapy, rheumatology, and dermatology. They collaborate with Pfizer, Roche, and Merck for oncology medications. For pain therapy, they offer a range of products including pain relievers and specialized therapies. In rheumatology, they focus on diseases of the musculoskeletal system such as osteoporosis and arthritis. They provide a wide range of medications and medical products tailored to these diseases. In dermatology, they specialize in treating skin conditions such as psoriasis and eczema, offering a variety of medications and medical products. They also offer other products including medical devices like injection needles, syringes, EKG machines, and ultrasound devices. Their business model is based on close collaboration with leading manufacturers and suppliers to ensure high-quality products. They also prioritize comprehensive consultation and support for their customers to ensure they receive the right products for their specific needs. In summary, Haemato AG is a leading company in the pharmaceutical and medical product trade, offering a wide range of products and collaborating with top manufacturers and suppliers to provide high-quality and comprehensive solutions for medical needs. Haemato ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Haemato's Profit Margins
The profit margins of Haemato represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Haemato's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Haemato's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Haemato's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Haemato’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Haemato Stock
How has the profit developed compared to last year?
The profit has increased by 28.06% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Haemato publish its earnings?
Haemato publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Haemato?
The profits of Haemato are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Haemato?
You can learn more about the earnings of Haemato by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Haemato pay?
Over the past 12 months, Haemato paid a dividend of 1.1 EUR . This corresponds to a dividend yield of about 6.4 %. For the coming 12 months, Haemato is expected to pay a dividend of 1.12 EUR.
What is the dividend yield of Haemato?
The current dividend yield of Haemato is 6.4 %.
When does Haemato pay dividends?
Haemato pays a quarterly dividend. This is distributed in the months of August, August, August, August.
How secure is the dividend of Haemato?
Haemato paid dividends every year for the past 0 years.
What is the dividend of Haemato?
For the upcoming 12 months, dividends amounting to 1.12 EUR are expected. This corresponds to a dividend yield of 6.49 %.
In which sector is Haemato located?
Haemato is assigned to the 'Health' sector.
Wann musste ich die Aktien von Haemato kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Haemato from 7/21/2023 amounting to 1.2 EUR, you needed to have the stock in your portfolio before the ex-date on 7/19/2023.
When did Haemato pay the last dividend?
The last dividend was paid out on 7/21/2023.
What was the dividend of Haemato in the year 2023?
In the year 2023, Haemato distributed 1.1 EUR as dividends.
In which currency does Haemato pay out the dividend?
The dividends of Haemato are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Haemato
Our stock analysis for Haemato Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Haemato Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.